Pharma channel feed

UC Davis mi­cro­bio­me spin­out re­brands in­fant sup­ple­ment busi­ness with na­ture fo­cus

3 years ago
R&D

Fin­ger­paint Group taps for­mer WPP and Mc­Cann Health ex­ec for new com­mer­cial role

3 years ago
Marketing

Af­ter Covid set­back, Val­ne­va lines up $100M for Pfiz­er-al­lied Ly­me dis­ease PhI­II

3 years ago
Financing
Coronavirus

Leo Phar­ma looks 'be­yond the skin' in atopic der­mati­tis aware­ness cam­paign

3 years ago
Marketing

Vlad Coric charts course for new Bio­haven with neu­ro­science push and Big Phar­ma vets on board

3 years ago

As­traZeneca de­buts an­noy­ing pur­ple ‘Phil’ crea­tures, per­son­i­fied asth­ma eosinophils ‘be­hav­ing bad­ly’

3 years ago
Marketing

Lentivi­ral vec­tor ramp-up: J&J and Leg­end to in­vest $500M in New Jer­sey man­u­fac­tur­ing to sup­port Carvyk­ti

3 years ago
Manufacturing

Mar­ket­ingRx roundup: No­var­tis re­cruits NFL coach for Leqvio cam­paign; Pfiz­er pro­motes ‘Sci­ence’ merch on so­cial me­dia

3 years ago
Marketing

Q&A: No­vo Nordisk dig­i­tal in­no­va­tion chief Amy West dis­cuss­es phar­ma pain points and a health­care 'easy but­ton’

3 years ago
Marketing

Paul Hud­son and Tri­alSpark's mu­tu­al de­sire to speed up de­vel­op­ment con­verges in three-year, six-drug goal

3 years ago
Deals

Bris­tol My­ers inks pro­tein de­grad­er deal via Cel­gene team's link to seed-stage biotech

3 years ago
Startups
Deals

Fa­ther starts lab af­ter in­tel­lec­tu­al prop­er­ty is­sues stymie rare dis­ease drug de­vel­op­ment

3 years ago
People
In Focus

Can a smart­phone app de­tect Covid? Pfiz­er throws down $116M to find out

3 years ago
Deals

Big Phar­ma heavy­weights seek tweaks to FDA's clin­i­cal out­come as­sess­ment guid­ance

3 years ago
FDA+

In­smed plots up­com­ing med launch­es built on its first drug lessons and con­sumer play­book mar­ket­ing strate­gies

3 years ago
Marketing

Roche hires new di­ag­nos­tics chief from with­in, ahead of C-suite shake-up

3 years ago
People

FTC chair Lina Khan pledges to use all tools to in­ves­ti­gate PBMs

3 years ago

#AAO22: J&J’s first look at com­mon eye dis­ease port­fo­lio pads the case for PhII of gene ther­a­py

3 years ago
R&D
Cell/Gene Tx

#AAO22: In bid for first FDA nod in ge­o­graph­ic at­ro­phy, Apel­lis claims an­oth­er first in eye dis­ease field

3 years ago
R&D

BioCryst launch­es aware­ness cam­paign around man­age­ment of rare vas­cu­lar dis­ease

3 years ago
Marketing

EMA makes new rec­om­men­da­tions for Im­bru­vi­ca, med­i­cines with ter­li­pressin over res­pi­ra­to­ry and car­dio­vas­cu­lar risks

3 years ago

New in­fla­tion-linked drug re­bates go in­to ef­fect on Sat­ur­day

3 years ago
Law

Mer­ck cel­e­brates an­oth­er win in Janu­via patent bat­tle against Vi­a­tris

3 years ago
Law

FDA's ad­vanced ther­a­pies of­fice pro­vides more clar­i­ty on gene ther­a­py CMC con­sid­er­a­tions

3 years ago
Cell/Gene Tx
Manufacturing
First page Previous page 169170171172173174175 Next page Last page
A service from the Financial Times